Anti-inflammatory treatment of atopic asthma guided by exhaled nitric oxide: a randomized, controlled trial.

[1]  J. Stockman.  Leukotriene Antagonists as First-Line or Add-on Asthma-Controller Therapy , 2013 .

[2]  Tonya S. King,et al.  Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. , 2012, JAMA.

[3]  C. Janson,et al.  Population-based study of multiplexed IgE sensitization in relation to asthma, exhaled nitric oxide, and bronchial responsiveness. , 2012, The Journal of allergy and clinical immunology.

[4]  Mario Castro,et al.  Asthma outcomes: composite scores of asthma control. , 2012, The Journal of allergy and clinical immunology.

[5]  J. Halterman,et al.  Asthma outcomes: quality of life. , 2012, The Journal of allergy and clinical immunology.

[6]  S. Willsie.  Daily exhaled nitric oxide measurements and asthma exacerbations in children , 2012 .

[7]  S. Willsie.  An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications , 2012 .

[8]  P. Gibson,et al.  Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial , 2011, The Lancet.

[9]  W. Crawford,et al.  Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. , 2011, The Journal of allergy and clinical immunology.

[10]  R. Vrtis,et al.  Effects of montelukast on patients with asthma after experimental inoculation with human rhinovirus 16. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[11]  A. Chang,et al.  A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils) , 2010, Thorax.

[12]  S. Willsie.  Quadrupling the Dose of Inhaled Corticosteroid to Prevent Asthma Exacerbations: A Randomized, Double-blind, Placebo-controlled, Parallel-Group Clinical Trial , 2010 .

[13]  A. Malinovschi,et al.  Basic aspects of exhaled nitric oxide , 2010 .

[14]  S. F. Jones.  Daily Telemonitoring of Exhaled Nitric Oxide and Symptoms in the Treatment of Childhood Asthma , 2010 .

[15]  J. Cowan,et al.  Outcomes using exhaled nitric oxide measurements as an adjunct to primary care asthma management. , 2009, Primary care respiratory journal : journal of the General Practice Airways Group.

[16]  M. Kaplan,et al.  Management of Asthma Based on Exhaled Nitric Oxide in Addition to Guideline-Based Treatment for Inner-City Adolescents and Young Adults: A Randomised Controlled Trial , 2009, Pediatrics.

[17]  J. Syk,et al.  Relationship between exhaled nitric oxide and IgE sensitisation in patients with asthma: influence of steroid treatment , 2009, The clinical respiratory journal.

[18]  I. Pavord,et al.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. , 2009, American journal of respiratory and critical care medicine.

[19]  Christer Janson,et al.  Asthma control in primary care in Sweden: a comparison between 2001 and 2005. , 2009, Primary care respiratory journal : journal of the General Practice Airways Group.

[20]  P. Gibson,et al.  Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  N. Zamel,et al.  The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma. , 2009, Respiratory medicine.

[22]  J. Fahy,et al.  Acute exacerbations of asthma: epidemiology, biology and the exacerbation‐prone phenotype , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  D. Price,et al.  High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study. , 2009, The Journal of allergy and clinical immunology.

[24]  D. Price,et al.  The Brussels Declaration: the need for change in asthma management , 2008, European Respiratory Journal.

[25]  L. Boulet,et al.  Overdiagnosis of asthma in obese and nonobese adults , 2008, Canadian Medical Association Journal.

[26]  I. Pavord,et al.  The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. , 2007, American journal of respiratory and critical care medicine.

[27]  I. Pavord,et al.  Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma , 2007, Thorax.

[28]  Richard Beasley,et al.  External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? , 2006, Thorax.

[29]  M. Hasselgren,et al.  Quality of Life and Measures of Asthma Control in Primary Health Care , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.

[30]  K. Torén,et al.  Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. , 2006, Chest.

[31]  F. Horak,et al.  Exhaled nitric oxide in the management of childhood asthma: A prospective 6‐months study , 2006, Pediatric pulmonology.

[32]  D. Taylor,et al.  Exhaled nitric oxide measurements: clinical application and interpretation , 2006, Thorax.

[33]  J. Kelso.  Titrating Steroids on Exhaled Nitric Oxide in Children With Asthma: A Randomized, Controlled Trial , 2006, Pediatrics.

[34]  B. Dahlén,et al.  Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge , 2006, European Respiratory Journal.

[35]  Linda Abetz,et al.  Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. , 2006, Respiratory medicine.

[36]  P. Hjemdahl,et al.  Brief questionnaires for patient-reported outcomes in asthma: validation and usefulness in a primary care setting. , 2006, Chest.

[37]  N. Thomson,et al.  Short and long-term effects of cigarette smoking independently influence exhaled nitric oxide concentration in asthma. , 2005, The Journal of allergy and clinical immunology.

[38]  J. Cowan,et al.  Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. , 2005, The New England journal of medicine.

[39]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[40]  H. Donninger,et al.  Rhinovirus Is Associated with Severe Asthma Exacerbations and Raised Nasal Interleukin-12 , 2002, Respiration.

[41]  E. Juniper,et al.  Measuring asthma control. Clinic questionnaire or daily diary? , 2000, American journal of respiratory and critical care medicine.

[42]  G. Guyatt,et al.  Development and validation of the Mini Asthma Quality of Life Questionnaire. , 1999, The European respiratory journal.

[43]  K. Svärdsudd,et al.  "The Göteborg quality of life instrument"--an assessment of well-being and symptoms among men born 1913 and 1923. Methods and validity. , 1990, Scandinavian journal of primary health care. Supplement.